JRCT ID: jRCT2033240156
Registered date:13/06/2024
Follow-up study of human induced Pluripotent Stem (iPS) cell-derived cardiomyocyte spheroids in patients with severe heart failure, secondary to ischemic heart disease, undergoing coronary artery bypass grafting
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Heart failure with ischemic heart disease |
Date of first enrollment | 13/06/2024 |
Target sample size | 10 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | To take immunosuppressant tacrolimus or other immunosuppressant |
Outcome(s)
Primary Outcome | Safety |
---|---|
Secondary Outcome | Safety |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 80age old |
Gender | Both |
Include criteria | Subjects who participated in the HS-001-01 study and were transplanted with HS-001CS and who were able to obtain voluntary consent in writing for inclusion in this clinical trial. |
Exclude criteria | Patients judged by the Investigator to be ineligible shall not be included in the Clinical Trial. |
Related Information
Primary Sponsor | Kaneko Takehiko |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Madoguchi Toiawase |
Address | 1-2-3, Shibaura, Minato-ku Tokyo Tokyo Japan 105-0023 |
Telephone | +81-3-6380-1068 |
chiken@heartseed.jp | |
Affiliation | Heartseed Inc |
Scientific contact | |
Name | Takehiko Kaneko |
Address | 1-2-3, Shibaura, Minato-ku Tokyo Tokyo Japan 105-0023 |
Telephone | +81-3-6380-1068 |
chiken@heartseed.jp | |
Affiliation | Heartseed Inc |